| Test purchase, synthesis, and characterization of 2‐methoxydiphenidine (MXP) and differentiation from its meta‐ and para‐substituted isomers G McLaughlin, N Morris, PV Kavanagh, JD Power, J O'Brien, B Talbot, ... Drug Testing and Analysis 8 (1), 98-109, 2016 | 41 | 2016 |
| Preparation and characterization of the ‘research chemical’diphenidine, its pyrrolidine analogue, and their 2, 2‐diphenylethyl isomers J Wallach, PV Kavanagh, G McLaughlin, N Morris, JD Power, SP Elliott, ... Drug Testing and Analysis 7 (5), 358-367, 2015 | 34 | 2015 |
| Fluorinated phenmetrazine “legal highs” act as substrates for high-affinity monoamine transporters of the SLC6 family FP Mayer, NV Burchardt, AM Decker, JS Partilla, Y Li, G McLaughlin, ... Neuropharmacology 134, 149-157, 2018 | 29 | 2018 |
| Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N‐methoxy positional isomer, N‐methoxymephedrone G McLaughlin, N Morris, PV Kavanagh, JD Power, G Dowling, B Twamley, ... Drug testing and analysis 9 (3), 358-368, 2017 | 25 | 2017 |
| The synthesis and characterization of the ‘research chemical’ N‐(1‐amino‐3‐methyl‐1‐oxobutan‐2‐yl)‐1‐(cyclohexylmethyl)‐3‐(4‐fluorophenyl)‐1H‐pyrazole‐5 … G McLaughlin, N Morris, PV Kavanagh, JD Power, B Twamley, J O'Brien, ... Drug Testing and Analysis 8 (9), 920-929, 2016 | 25 | 2016 |
| Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3′, 4′‐methylenedioxy‐4‐methylaminorex (MDMAR) G McLaughlin, N Morris, PV Kavanagh, JD Power, B Twamley, J O'Brien, ... Drug testing and analysis 7 (7), 555-564, 2015 | 23 | 2015 |
| Forensic analysis of P2P derived amphetamine synthesis impurities: identification and characterization of indene by‐products JD Power, P Kavanagh, G McLaughlin, G Dowling, M Barry, J O'Brien, ... Drug Testing and Analysis 9 (3), 446-452, 2017 | 18 | 2017 |
| In vitro metabolism of the synthetic cannabinoid 3,5‐AB‐CHMFUPPYCA and its 5,3‐regioisomer and investigation of their thermal stability F Franz, V Angerer, SD Brandt, G McLaughlin, PV Kavanagh, ... Drug Testing and Analysis 9 (2), 311-316, 2017 | 18 | 2017 |
| The pharmacokinetic interaction between ivacaftor and ritonavir in healthy volunteers AM Liddy, G McLaughlin, S Schmitz, DM D'Arcy, MG Barry British journal of clinical pharmacology 83 (10), 2235-2241, 2017 | 17 | 2017 |
| Test purchase, synthesis and characterization of 3‐fluorophenmetrazine (3‐FPM) and differentiation from its ortho‐ and para‐substituted isomers G McLaughlin, N Morris, PV Kavanagh, G Dowling, JD Power, B Twamley, ... Drug Testing and analysis 9 (3), 369-377, 2017 | 16 | 2017 |
| Analytical characterization and pharmacological evaluation of the new psychoactive substance 4‐fluoromethylphenidate (4F‐MPH) and differentiation between the (±)‐threo and … G McLaughlin, N Morris, PV Kavanagh, JD Power, G Dowling, B Twamley, ... Drug testing and analysis 9 (3), 347-357, 2017 | 15 | 2017 |
| ‘APAAN in the neck’-A reflection on some novel impurities found in seized materials containing amphetamine in Ireland during routine forensic analysis. JD Power, P Kavanagh, G McLaughlin, M Barry, D Dowling, SD Brandt Drug Testing and Analysis 9 (7), 966-976, 2017 | 12 | 2017 |
| Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4‐methylphenmetrazine (4‐MPM), with differentiation from its ortho … G McLaughlin, MH Baumann, PV Kavanagh, N Morris, JD Power, ... Drug testing and analysis 10 (9), 1404-1416, 2018 | 9 | 2018 |
| Outsmarted by nootropics? An investigation into the thermal degradation of modafinil, modafinic acid, adrafinil, CRL‐40,940 and CRL‐40,941 in the GC injector: formation of 1, 1 … G Dowling, PV Kavanagh, B Talbot, J O’Brien, G Hessman, G McLaughlin, ... Drug Testing and Analysis 9 (3), 518-528, 2017 | 8 | 2017 |
| An approach to shortening the timeframe between the emergence of new compounds on the drugs market and the availability of reference standards: The microscale syntheses of … G Dowling, PV Kavanagh, HG Eckhardt, B Twamley, G Hessman, ... Drug Testing and Analysis 10 (7), 1198-1208, 2018 | 6 | 2018 |
| Outsmarted by nootropics G Dowling, PV Kavanagh, B Talbot, J O’Brien, G Hessman, G McLaughlin, ... An investigation into the thermal degradation of modafinil, modafinic acid …, 2016 | 6 | 2016 |
| Identification and characterization of an imidazolium by‐product formed during the synthesis of 4‐methylmethcathinone (mephedrone) JD Power, P Kavanagh, G McLaughlin, J O'Brien, B Talbot, M Barry, ... Drug Testing and Analysis 7 (10), 894-902, 2015 | 6 | 2015 |
| An unusual detection of 2‐amino‐3‐(2‐chlorobenzoyl)‐5‐ethylthiophene and 2‐methylamino‐5‐chlorobenzophenone in illicit yellow etizolam tablets marked “5617” seized in the … C Downey, A O'Donnell, G McLaughlin, G O'Neill, J O'Brien, PV Kavanagh Drug Testing and Analysis 14 (3), 531-538, 2022 | 2 | 2022 |
| Test purchase, synthesis and characterization of 2-methoxydiphenidine (MXP) and differentiation from its metaand para-substituted isomers. N Morris, G McLaughlin, PV Kavanagh, JD Power, J O'Brien, B Talbot, ... Drug Testing and Analysis, 2015 | | 2015 |
| Evaluation of the Monoamine Transporter Activities of the New Psychoactive Substances (NPS) 4, 4’-dimethylaminorex (4, 4’-DMAR) and 3’, 4’-methylenedioxy-4-methylaminorex (MDMAR. G McLaughlin, N Morris, PV Kavanagh, B Twamley, J O'Brien, B Talbot, ... | | 2014 |
